ITEMS IN AFP WITH KEYWORD:

Substance Abuse

May 15, 2018 Issue
Implantable Buprenorphine (Probuphine) for Maintenance Treatment of Opioid Use Disorder [STEPS]

Implantable buprenorphine is an expensive alternative for patients on a stable dosage of transmucosal buprenorphine. Based on current research and guidance, implantable buprenorphine should not be used as initial treatment for opioid dependence or as a substitute for medication-assisted treatments other than transmucosal buprenorphine.


Mar 1, 2018 Issue
Buprenorphine Therapy for Opioid Use Disorder [Article]

Get the DSM-5 updates on opioid use disorder, and find out whether you meet the criteria for a waiver to prescribe buprenorphine for maintenance therapy in the office setting.


Mar 1, 2018 Issue
Treating Opioid Use Disorder as a Family Physician: Taking the Next Step [Editorials]

An AHRQ review showed that there are different ways in which buprenorphine-based MAT can be safely and effectively delivered in primary care settings.


Nov 1, 2017 Issue
Interventions for Tobacco Cessation in Patients Being Treated for or Recovering from Substance Use Disorders [Cochrane for Clinicians]

Pharmacotherapy alone and pharmacotherapy plus counseling are effective for tobacco cessation among patients being treated for or recovering from alcohol and substance use disorders. Counseling interventions without pharmacotherapy are not effective for tobacco cessation among patients in treatment for or recovery from substance use disorders.


Sep 15, 2017 Issue
How Family Physicians Can Combat the Opioid Epidemic [Editorials]

Family physicians must commit to responsible prescribing of opioid medications. The decision to initiate opioid therapy should be a careful and deliberate one, especially in patients who are at risk of addiction.


Apr 1, 2017 Issue
Chronic Pain Management and Opioid Misuse: Guidance for Family Physicians [Editorials]

Family physicians are committed to advancing population and community health, and we must take the lead in reducing opioid misuse and overdose before outside entities mandate practice strategies that may not be patient-centered.


Apr 1, 2017 Issue
Management of Chronic Pain and Opioid Misuse: A Position Paper from the AAFP [Practice Guidelines]

Overprescribing, misuse, diversion, and dependence on opioids have occurred as a result of external pressures, physician behavior, inadequate evidence, and pharmacologic development. Family physicians could play an important role in alleviating these problems; therefore, the American Academy of Fami...


Mar 1, 2017 Issue
Buprenorphine Maintenance vs. Placebo for Opioid Dependence [Medicine by the Numbers]

Buprenorphine causes lower physical dependence, milder withdrawal symptoms, and is less likely to cause an overdose than methadone in the treatment of opioid dependence.


Jan 1, 2017 Issue
Alpha-adrenergic Agonists for the Management of Opioid Withdrawal [Medicine by the Numbers]

Alpha-adrenergic agonists were more efficacious than placebo in the management of opioid withdrawal, but are best reserved as an alternative to methadone.


Oct 1, 2016 Issue
Rural Opioid Use Disorder Treatment Depends on Family Physicians [Graham Center Policy One-Pagers]

The nation's growing opioid use disorder epidemic disproportionately impacts rural areas, where physicians who can prescribe buprenorphine are scarcest. Among physicians approved to prescribe buprenorphine, family physicians (FPs) are the most likely to work in rural areas.


Pages: 1 2 3 4 Next


Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now